Grupo Espanol de Tumores Neuroendocrinos (GETNE)   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Barcelona Spain (2004)

Organization Overview

First Clinical Trial
2010
NCT01280201
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Grupo Espanol de Tumores Neuroendocrinos